"Prenatal Testing and New-born Screening Market - Industry Trends and Forecast to 2028
Global Prenatal Testing and New-born Screening Market, By Type (New-born Screening, Prenatal Testing), Test (Non-Invasive, Invasive), Product (Ultrasonography, Tandem Quadrupole Detector, Reagent and Assay Kits, Hearing Screen Instruments, Incubator Shaker), Technology (Screening Technology, Diagnostic Technology, Mass Spectrometry, Enzyme Immunoassays, Electrophoresis, DNA Assays), End User (Hospitals, Diagnostic Centres, Maternity and Specialty Clinics), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Access Full 350 Pages PDF Report @
**Segments**
- **Prenatal Testing Market**: The prenatal testing market is experiencing significant growth due to the increasing demand for early detection of genetic disorders and chromosomal abnormalities in fetuses. Non-invasive prenatal testing (NIPT) is a key segment within this market, allowing for accurate screening of fetal DNA in the maternal bloodstream. The market is driven by the rising awareness among pregnant women about the benefits of prenatal testing in preventing birth defects and disorders.
- **Newborn Screening Market**: Newborn screening involves the testing of infants shortly after birth to identify any genetic, metabolic, or developmental conditions that may not be apparent at birth. This market segment is growing due to the expanding newborn screening programs worldwide, aimed at early detection and intervention to prevent long-term health complications. Advances in technology have improved the accuracy and efficiency of newborn screening tests, driving the market's growth.
**Market Players**
- **PerkinElmer, Inc.**: PerkinElmer is a leading player in the prenatal testing and newborn screening market, offering a range of innovative solutions for genetic testing and early disease detection. Their advanced testing platforms and genetic screening tools have contributed to the overall growth of the market.
- **F. Hoffmann-La Roche Ltd**: Roche is a key player in the healthcare industry, with a strong presence in prenatal testing and newborn screening markets. Their diagnostic technology and products play a vital role in identifying genetic disorders and ensuring timely interventions for newborns.
- **Natera, Inc.**: Natera specializes in NIPT and other prenatal genetic testing services, providing accurate and reliable results for expectant mothers. The company's focus on innovation and research has positioned them as a prominent player in the prenatal testing market.
- **Bio-Rad Laboratories, Inc.**: Bio-Rad is a renowned manufacturer of diagnostic products, including testing kits for newborn screening and prenatal genetic testing. Their expertise in developing high-quality assays and testing solutions has established them as a trusted player in the market.
-The prenatal testing and newborn screening markets have been witnessing significant growth in recent years, driven by various factors such as increasing awareness among pregnant women, advancements in technology, and expanding healthcare initiatives focused on early disease detection and prevention. These markets play a crucial role in identifying genetic disorders, chromosomal abnormalities, metabolic conditions, and developmental issues in fetuses and newborns, allowing for timely interventions and treatment plans. The demand for non-invasive prenatal testing (NIPT) has been particularly noteworthy, as it offers accurate and reliable screening of fetal DNA in the maternal bloodstream, thereby reducing the risk of birth defects and disorders. As expectant mothers become more informed about the benefits of prenatal testing, the market is expected to continue its growth trajectory.
Market players such as PerkinElmer, Inc., F. Hoffmann-La Roche Ltd, Natera, Inc., and Bio-Rad Laboratories, Inc. have been at the forefront of innovation and research in the prenatal testing and newborn screening segments. These companies have developed advanced testing platforms, diagnostic technologies, and genetic screening tools that have significantly contributed to the overall growth and development of the market. PerkinElmer's wide range of solutions for genetic testing and early disease detection have positioned them as a leading player in the industry, while Roche's diagnostic technology and products have been instrumental in identifying genetic disorders and ensuring timely interventions for newborns. Natera's focus on NIPT and prenatal genetic testing services has garnered them a strong reputation for providing accurate and reliable results, further solidifying their presence in the market. Bio-Rad's expertise in developing high-quality assays and testing solutions has made them a trusted partner for healthcare providers and researchers in the field of newborn screening and prenatal genetic testing.
Looking ahead, the prenatal testing and newborn screening markets are poised for continued growth, driven by ongoing technological advancements, increasing healthcare investments, and a growing emphasis on preventive healthcare measures. As the global population continues to grow, the demand for early detection and intervention strategies for genetic**Global Prenatal Testing and New-born Screening Market:**
- New-born Screening
- Prenatal Testing
**Test:**
- Non-Invasive
- Invasive
**Product:**
- Ultrasonography
- Tandem Quadrupole Detector
- Reagent and Assay Kits
- Hearing Screen Instruments
- Incubator Shaker
**Technology:**
- Screening Technology
- Diagnostic Technology
- Mass Spectrometry
- Enzyme Immunoassays
- Electrophoresis
- DNA Assays
**End User:**
- Hospitals
- Diagnostic Centres
- Maternity and Specialty Clinics
**Country:**
- U.S.
- Canada
- Mexico
- Germany
- Italy
- U.K.
- France
- Spain
- Netherland
- Belgium
- Switzerland
- Turkey
- Russia
- Rest of Europe
- Japan
- China
- India
- South Korea
- Australia
- Singapore
- Malaysia
- Thailand
- Indonesia
- Philippines
- Rest of Asia-Pacific
- Brazil
- Argentina
- Rest of South America
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Israel
- Rest of Middle East and Africa
The global prenatal testing and newborn screening market is witnessing significant growth fueled by various factors such as increasing awareness among pregnant women, advancements in technology, and expanding healthcare initiatives for early disease detection and prevention. The
Table of Contents: Prenatal Testing and New-born Screening Market
1 Introduction
2 Global Prenatal Testing and New-born Screening Market Segmentation
3 Executive Summary
4 Premium Insight
5 Market Overview
6 Prenatal Testing and New-born Screening Market, by Product Type
7 Prenatal Testing and New-born Screening Market, by Modality
8 Prenatal Testing and New-born Screening Market, by Type
9 Prenatal Testing and New-born Screening Market, by Mode
10 Prenatal Testing and New-born Screening Market, by End User
12 Prenatal Testing and New-born Screening Market, by Geography
12 Prenatal Testing and New-born Screening Market, Company Landscape
13 Swot Analysis
14 Company Profiles
Countries Studied:
- North America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
- Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
- Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
- Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Objectives of the Report
- To carefully analyze and forecast the size of the Prenatal Testing and New-born Screening market by value and volume.
- To estimate the market shares of major segments of the Prenatal Testing and New-born Screening
- To showcase the development of the Prenatal Testing and New-born Screening market in different parts of the world.
- To analyze and study micro-markets in terms of their contributions to the Prenatal Testing and New-born Screening market, their prospects, and individual growth trends.
- To offer precise and useful details about factors affecting the growth of the Prenatal Testing and New-born Screening
- To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Prenatal Testing and New-born Screening market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.
Browse Trending Reports:
Hub Motor Market
Surgical Endoscopes Market
Contrast And Imaging Agents In Interventional x Ray Market
Rtd Protein Beverages Market
Transdermal Gel Market
Natural And Synthetic Biomedical Adhesives Market
Licensed Sports Merchandise Market
Percutaneous Nephroscope Market
Compressor Oil Market
Respiratory Disposables And Reusable Accessories Market
Viral Clearance Services Market
Biostimulants Market
Unmanned Ground Vehicle Market
Parkinsons Disease Market
Induced Pluripotent Stem Cells Market
Composite Cans Market
Malt Ingredients Market
Pharmaceutical Glass Packaging Market
Gan Power Device Market
Espresso Coffee Market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975